The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. The guideline is based on the 2016 WHO classification of tumours of the CNS and on scientific developments published since 1980. It aims to provide direction for diagnostic and management decisions, and for limiting unnecessary treatments and cost. In view of the scarcity of data in adults with medulloblastoma, we base our recommendations on adult data when possible, but also include recommendations derived from paediatric data if justified. Our recommendations are a resource for professionals involved in the management of...
WOS: 000433102000015PubMed ID: 29373196Background and purpose: The optimal treatment for adults with...
The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We ...
The authors intend to present in this paper the most actual trends and perspectives in the challengi...
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provi...
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provi...
Recent advances in molecular profiling, have reclassified medulloblastoma, an undifferentiated tumor...
Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa belonging to the family o...
The literature on medulloblastoma in adults is generally limited to case reports and retrospective s...
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate...
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care...
Introduction: Medulloblastoma (MB) is the most common primary malignant intracranial tumor in childh...
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care...
Simple Summary Medulloblastoma is rare after puberty. Among several molecular subgroups that have b...
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate...
Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) h...
WOS: 000433102000015PubMed ID: 29373196Background and purpose: The optimal treatment for adults with...
The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We ...
The authors intend to present in this paper the most actual trends and perspectives in the challengi...
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provi...
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provi...
Recent advances in molecular profiling, have reclassified medulloblastoma, an undifferentiated tumor...
Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa belonging to the family o...
The literature on medulloblastoma in adults is generally limited to case reports and retrospective s...
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate...
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care...
Introduction: Medulloblastoma (MB) is the most common primary malignant intracranial tumor in childh...
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care...
Simple Summary Medulloblastoma is rare after puberty. Among several molecular subgroups that have b...
Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate...
Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) h...
WOS: 000433102000015PubMed ID: 29373196Background and purpose: The optimal treatment for adults with...
The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We ...
The authors intend to present in this paper the most actual trends and perspectives in the challengi...